Skip to main content
Premium Trial:

Request an Annual Quote

'There in Places'

At What Matters, Rik Kirkland speaks with Esther Dyson, one of the Personal Genome Project 10 (totally different than the Oceanic Six) and a board member of 23andMe, about health, healthcare, and genetics. Dyson says that everything -- as exemplified by the Internet -- is turning into a "market of one." Though she says personalized medicine has begun, pointing to different treatments and prognoses for certain types of breast cancer, Dyson says the switchover isn't complete. "We're there in places, but we're very, very far from being there in general. This is something that people should want to do or volunteer to do, not something that should be imposed on them," she says, adding that she expects to see a change in how healthcare is delivered within the next five to 10 years.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.